Summary

KEY FINDINGS
The global insulin patch pumps market is anticipated to grow with a CAGR of 10.63% in terms of revenue during the forecast years of 2023-2032. Some of the top drivers bolstering the growth of the market include the rising incidence of diabetes, technological advancements, and surging awareness about patch pumps.
MARKET INSIGHTS
Insulin patch pumps are efficient devices owing to their relatively smaller size compared to traditional insulin pumps. Furthermore, these pumps are more affordable and easier to use than conventional systems, as well. Due to advancements in technology, these pumps require minimum monitoring, which further increases their demand.
The discrete nature of these devices is one of the leading factors increasing their adoption among the younger population. Moreover, the rise in the frequency of product launches, coupled with collaborations between key market players as well as technology developers, is anticipated to raise awareness regarding insulin patch pumps, leading to significant market growth. Additionally, the availability of custom-made patch pumps is also set to increase the devices’ popularity during the projection period.
REGIONAL INSIGHTS
The global insulin patch pumps market growth is evaluated through the analysis of North America, Europe, the Asia-Pacific, and Rest of World. North America dominated the global insulin patch pumps market in 2022. The market growth of the region is primarily fueled by rising healthcare expenditure, the surge in per capita income, and the increasing prevalence of diabetes.
COMPETITIVE INSIGHTS
The industry rivalry in the global insulin patch pumps market is set to be high during the forecast period. Furthermore, key enterprises operating in the global market are Medtronic PLC, Insulet Corporation, F. Hoffmann-La Roche Ltd, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING OCCURRENCE OF DIABETES
2.5.2. GROWING HEALTHCARE AWARENESS
2.5.3. TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS
2.5.4. INCREASING RESEARCH AND DEVELOPMENT IN MEDICAL DEVICES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING PREVALENCE OF DIABETES
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN INSULIN PATCH PUMPS
3.1.3. RISING AWARENESS ABOUT PATCH PUMPS
3.2. KEY RESTRAINTS
3.2.1. STRINGENT GOVERNMENT REGULATIONS
3.2.2. RISKS ASSOCIATED WITH THE USE OF PUMPS
3.2.3. LACK OF KNOWLEDGE LIMITS THE ADOPTION
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT MANUFACTURING
4.7.3. SALES AND DISTRIBUTION
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. PRODUCT FEATURES
4.8.3. USABILITY
5. MARKET BY TYPE
5.1. DISPOSABLE
5.2. REUSABLE
6. MARKET BY DELIVERY MODE
6.1. BASAL
6.2. BOLUS
6.3. BASAL & BOLUS
7. MARKET BY DISEASE INDICATION
7.1. TYPE 1 DIABETES
7.2. TYPE 2 DIABETES
8. MARKET BY DISTRIBUTION CHANNEL
8.1. HOSPITAL PHARMACIES
8.2. RETAIL PHARMACIES
8.3. ONLINE PHARMACIES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. NORTH AMERICA INSULIN PATCH PUMPS MARKET DRIVERS
9.1.3. NORTH AMERICA INSULIN PATCH PUMPS MARKET CHALLENGES
9.1.4. NORTH AMERICA INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.1.5. KEY PLAYERS IN NORTH AMERICA INSULIN PATCH PUMPS MARKET
9.1.6. COUNTRY ANALYSIS
9.1.6.1. UNITED STATES
9.1.6.1.1. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.2. CANADA
9.1.6.2.1. CANADA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. EUROPE INSULIN PATCH PUMPS MARKET DRIVERS
9.2.3. EUROPE INSULIN PATCH PUMPS MARKET CHALLENGES
9.2.4. EUROPE INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.2.5. KEY PLAYERS IN EUROPE INSULIN PATCH PUMPS MARKET
9.2.6. COUNTRY ANALYSIS
9.2.6.1. UNITED KINGDOM
9.2.6.1.1. UNITED KINGDOM INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.2. GERMANY
9.2.6.2.1. GERMANY INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.3. FRANCE
9.2.6.3.1. FRANCE INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.4. ITALY
9.2.6.4.1. ITALY INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.5. SPAIN
9.2.6.5.1. SPAIN INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.6. SWITZERLAND
9.2.6.6.1. SWITZERLAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.7. POLAND
9.2.6.7.1. POLAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.2.6.8. REST OF EUROPE
9.2.6.8.1. REST OF EUROPE INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET DRIVERS
9.3.3. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET CHALLENGES
9.3.4. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.3.5. KEY PLAYERS IN ASIA-PACIFIC INSULIN PATCH PUMPS MARKET
9.3.6. COUNTRY ANALYSIS
9.3.6.1. CHINA
9.3.6.1.1. CHINA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.2. JAPAN
9.3.6.2.1. JAPAN INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.3. INDIA
9.3.6.3.1. INDIA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.4. SOUTH KOREA
9.3.6.4.1. SOUTH KOREA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.5. INDONESIA
9.3.6.5.1. INDONESIA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.6. THAILAND
9.3.6.6.1. THAILAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.7. VIETNAM
9.3.6.7.1. VIETNAM INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.8. AUSTRALIA & NEW ZEALAND
9.3.6.8.1. AUSTRALIA & NEW ZEALAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.3.6.9. REST OF ASIA-PACIFIC
9.3.6.9.1. REST OF ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. REST OF WORLD INSULIN PATCH PUMPS MARKET DRIVERS
9.4.3. REST OF WORLD INSULIN PATCH PUMPS MARKET CHALLENGES
9.4.4. REST OF WORLD INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.4.5. KEY PLAYERS IN REST OF WORLD INSULIN PATCH PUMPS MARKET
9.4.6. REGIONAL ANALYSIS
9.4.6.1. LATIN AMERICA
9.4.6.1.1. LATIN AMERICA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.4.6.2. MIDDLE EAST & AFRICA
9.4.6.2.1. MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.2. COMPANY PROFILES
10.2.1. CEQUR SA
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCTS / SERVICES LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. DEBIOTECH SA
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCTS / SERVICES LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. EOFLOW CO LTD
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCTS / SERVICES LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. F. HOFFMANN-LA ROCHE LTD
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCTS / SERVICES LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. INSULET CORPORATION
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCTS / SERVICES LIST
10.2.5.3. STRENGTHS & CHALLENGES
10.2.6. MEDTRONIC PLC
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCTS / SERVICES LIST
10.2.6.3. STRENGTHS & CHALLENGES
10.2.7. MEDTRUM TECHNOLOGIES INC
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCTS / SERVICES LIST
10.2.7.3. STRENGTHS & CHALLENGES
10.2.8. TANDEM DIABETES CARE INC
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCTS / SERVICES LIST
10.2.8.3. STRENGTHS & CHALLENGES
10.2.9. TERUMO CORPORATION
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCTS / SERVICES LIST
10.2.9.3. STRENGTHS & CHALLENGES